This article is more than 5 years old. Information may no longer be current.

VIDEO: Alimera expects profitability from Iluvien in 2018

ByDan Myers

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

NEW ORLEANS ― At the Ophthalmology Innovation Summit here, Dan Myers, CEO of Alimera Sciences, updates the success Iluvien is having within the market.